Product image of Hypotron (Midodrine Hydrochloride) supplied by GNH India

Hypotron

Active Ingredient:
Midodrine Hydrochloride
Origin:
EU

Hypotron (Midodrine Hydrochloride)

Midodrine Hydrochloride, the active ingredient in Hypotron, is an Alpha-1 adrenergic agonist presented as an oral dosage form for oral use. It is employed to raise blood pressure in patients with orthostatic hypotension, helping to reduce dizziness and fainting episodes. It is indicated for adults who experience a significant drop in systolic blood pressure upon standing, a condition that can impair daily activities.

GNH India supplies Hypotron as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, adhering to stringent quality standards and regulatory requirements across the EU and other markets.

Manufacturer / TM Owner

Brancaster Pharma Ireland Ltd.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Midodrine Hydrochloride is used to manage orthostatic hypotension, a disorder of autonomic blood pressure regulation.

  • Orthostatic hypotension: raises standing systolic blood pressure and reduces dizziness or fainting.
  • Neurogenic orthostatic hypotension: improves vascular tone in patients with autonomic failure.
  • Postural hypotension: helps maintain blood pressure upon standing, supporting daily activities.

How It Works

  • Midodrine Hydrochloride is a prodrug that is rapidly converted to desglymidodrine, an active metabolite that selectively stimulates peripheral alpha‑1 adrenergic receptors. Activation of these receptors induces vasoconstriction of arterioles and veins, increasing systemic vascular resistance and thereby elevating arterial blood pressure, particularly in the upright position.

Side Effects

Common side effects are generally mild and related to its vasoconstrictive action.

Common Side Effects

  • Supine hypertension: elevated blood pressure when lying down.
  • Piloerection: goose‑flesh skin reaction.
  • Pruritus: itching, often on the scalp.
  • Urinary retention: difficulty emptying the bladder.
  • Nausea: mild gastrointestinal upset.
  • Scalp tingling: transient paresthesia.

Serious or Rare Side Effects

  • Severe hypertension: potentially dangerous rise in blood pressure.
  • Myocardial infarction: rare heart attack risk.
  • Arrhythmia: abnormal heart rhythm.
  • Ischemic stroke: rare cerebrovascular event.
  • Severe urinary retention requiring catheterisation.
  • Anaphylaxis: extremely rare allergic reaction.

Precautions & Warnings

Patients and prescribers should observe several safety measures when using Hypotron.

  • Monitor blood pressure: check both supine and standing values regularly.
  • Avoid in severe cardiac disease: risk of excessive hypertension.
  • Caution with renal impairment: dose adjustment may be needed.
  • Review concomitant antihypertensives: potential additive blood‑pressure effects.
  • Educate on supine hypertension: advise patients to avoid lying flat after dosing.
  • Store at room temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Midodrine Hydrochloride can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Other vasopressors (e.g., phenylephrine): risk of severe hypertension.
  • Monoamine oxidase inhibitors: potential hypertensive crisis.
  • Clonidine withdrawal: unpredictable blood‑pressure changes.

Moderate Interactions (Monitor Closely)

  • Diuretics: may enhance orthostatic blood‑pressure fluctuations.
  • Beta‑blockers: may blunt compensatory tachycardia.
  • Anticholinergic agents: may increase urinary retention risk.

Frequently Asked Questions

Hypotron contains midodrine hydrochloride and is prescribed to treat orthostatic hypotension, a condition where blood pressure falls upon standing, causing dizziness, light‑headedness, or fainting. It helps raise standing blood pressure and improve patient stability.

Midodrine is a prodrug that is converted in the body to desglymidodrine, which selectively activates peripheral alpha‑1 adrenergic receptors. This activation causes blood vessels to constrict, increasing systemic vascular resistance and thereby raising arterial blood pressure, especially when upright.

The dosage of Hypotron is determined by the prescribing clinician based on the individual’s blood‑pressure response, severity of symptoms, and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for midodrine hydrochloride in pregnancy and lactation are limited. The prescriber should evaluate the potential benefits against possible risks before prescribing Hypotron to pregnant or nursing individuals.

To request Hypotron, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other agents such as fludrocortisone, midodrine directly stimulates vascular alpha‑1 receptors, producing a rapid increase in blood pressure without relying on fluid retention. This mechanism can be advantageous for patients who need prompt symptom relief, though individual response varies.

Hypotron should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency.

Hypotron is taken orally, usually with a full glass of water. It is typically administered during the day and avoided close to bedtime to reduce the risk of supine hypertension.

The most serious risks include severe hypertension, especially when lying down, and rare cardiovascular events such as myocardial infarction or stroke. Patients should be monitored for sudden increases in blood pressure and report any chest pain or neurological symptoms immediately.

Hypotron is contraindicated in patients with severe organic heart disease, acute renal failure, or known hypersensitivity to midodrine. It should also be avoided in individuals with uncontrolled hypertension or those taking other potent vasoconstrictors without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Midodrine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT